A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
Recruiting · NCT07493135 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Early phase 1 | 2026-09-03 | NCT07493135 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Immunofoco Biotechnology Co., Ltd | 5 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing GoBroad Boren Hospital | Beijing | China | 5 |
| Renji Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai | China | 9 |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing | China | 13 |
| Zhengzhou Yihe Hospital | Zhengzhou | China | 1 |